Dermapharm Holding SE
DMPHF
$38.50
-$2.12-5.23%
OTC PK
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Net Income | -32.54% | 60.81% | -38.61% | 91.60% | -60.75% |
| Total Depreciation and Amortization | 8.40% | 171.98% | -230.38% | -6.76% | 12.49% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 208.42% | -207.56% | -57.37% | 420.36% | -195.69% |
| Change in Net Operating Assets | 142.77% | -247.84% | 1,086.15% | 120.92% | 70.82% |
| Cash from Operations | 1,580.85% | -94.18% | -5.60% | 228.76% | -31.43% |
| Capital Expenditure | -11.79% | 16.28% | -48.14% | 31.14% | -62.16% |
| Sale of Property, Plant, and Equipment | -77.02% | 37.90% | 126.28% | -96.67% | 2,759.05% |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 10.13% | -89.68% | 249.35% | 300.73% | -354.73% |
| Cash from Investing | -15.22% | -21.26% | -12.22% | 23.99% | -29.83% |
| Total Debt Issued | 0.00% | 213.34% | 11.70% | -88.89% | -- |
| Total Debt Repaid | -104.44% | 78.71% | -15.96% | -17.02% | -2.35% |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | 100.00% | -- | -- |
| Other Financing Activities | 38.88% | -194.41% | 63.74% | -183.24% | 64.77% |
| Cash from Financing | -4,839.84% | 99.77% | 47.26% | -439.36% | 150.55% |
| Foreign Exchange rate Adjustments | -118.23% | -201.32% | 281.24% | -958.47% | 88.77% |
| Miscellaneous Cash Flow Adjustments | 200.00% | -200.00% | -- | -- | -200.00% |
| Net Change in Cash | 938.62% | -303.10% | 106.07% | -200.12% | 215.98% |